Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits.
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
Effects Of A Novel Orally Administered Calpain Inhibitor Snj-1945 On Immunomodulation And Neurodegeneration In A Murine Model Of Multiple Sclerosis.
Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.
Immunosuppressive treatments in multiple sclerosis.
Evidence for classic complement activity in neuromyelitis optica.
Primary varicella zoster infection associated with fingolimod treatment.
Diet, microbiota and autoimmune diseases.
HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis.
Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.
A dorsiflexion assist orthosis reduces the physiological cost and mitigates deterioration in strength and balance associated with walking in people with Multiple Sclerosis.
Multiple sclerosis: managing a complex neurological disease.
Using Functional Electrical Stimulation Mediated by Iterative Learning Control and Robotics to Improve Arm Movement for People With Multiple Sclerosis.
Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination.
Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis.
Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain.
Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
Neuromyelitis optica in children: a review of the literature.
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation.
MicroRNA dysregulation in multiple sclerosis.
Cognitive function in multiple sclerosis: a subcortical pattern of neuropsychological impairment?
Cervical dysplasia associated with the use of natalizumab.
Simulating neurodegeneration through longitudinal population analysis of structural and diffusion weighted MRI data.
Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA).
The Future of Research in Multiple Sclerosis.

Pages